HUMA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 23.10%

Insider Buying (Last 12 Months): $369,107.20

Insider Selling (Last 12 Months): $24,894,117.56

Humacyte Insider Trading History Chart

Humacyte Share Price & Price History

^$5.62

▼ -0.07 (-1.23%)

As of 09/12/2024 01:00 AM ET

Days: 30 | 90 | 365

Trader Books $13M Profit on “Nvidia of Crypto”

From Crypto 101 Media | Ad

A position trader recently booked an estimated $13.2 million profit on a single crypto currency… This little-known coin, dubbed the "Nvidia of crypto," is fueling the artificial intelligence boom – allowing top companies to train their AI systems without the need for expensive microchips.

Click here to review my research and the strategy I've developed for the opportunity to trade this c

Humacyte Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/10/2024	Kathleen Sebelius	Director	Sell	5,182	$5.40	$27,982.80	40,276
9/9/2024	Laura E. Niklason	CEO	Sell	157,704	$5.42	$854,755.68	3,519,558
8/29/2024	Brady W. Dougan	Director	Sell	352,112	$6.35	$2,235,911.20	3,677,262
8/28/2024	Laura E. Niklason	CEO	Sell	277,090	$6.47	$1,792,772.30	4,029,374
8/27/2024	Brady W. Dougan	Director	Sell	252,676	$6.71	$1,695,455.96	4,306,464
8/27/2024	Dale A Sander	CFO	Sell	39,389	$6.68	$263,118.52	2,000
6/12/2024	Brady W. Dougan	Director	Sell	271,518	$7.30	$1,982,081.40	4,559,140
6/11/2024	Laura E. Niklason	CEO	Sell	358,630	$7.08	$2,539,100.40	4,830,658
6/4/2024	Brady W. Dougan	Director	Buy	2,362	$6.35	$14,998.70	240,832
6/3/2024	Laura E. Niklason	CEO	Buy	2,050	$7.37	$15,108.50	238,470
5/31/2024	Laura E. Niklason	CEO	Sell	809,786	$7.91	$6,405,407.26	5,381,354
5/30/2024	Heather Ledbetter Prichard	COO	Sell	188,886	$8.14	$1,537,532.04	2,625
5/15/2024	Gordon M Binder	Director	Buy	50,000	$6.78	$339,000.00	160,000
9/14/2023	Laura E. Niklason	CEO	Sell	2,000,000	$2.78	$5,560,000.00	6,191,140
8/21/2023	Laura E. Niklason	CEO	Sell	602,443	$3.39	$2,042,281.77	8,191,140
8/18/2023	Brady W. Dougan	Director	Sell	626,979	$3.57	$2,238,315.03	8,793,583
8/17/2023	Laura E. Niklason	CEO	Sell	570,174	$3.68	$2,098,240.32	9,420,562
6/15/2023	Laura E. Niklason	CEO	Sell	500,000	$3.12	$1,560,000.00	9,990,736
6/13/2023	Laura E. Niklason	CEO	Sell	4,875,000	$2.60	$12,675,000.00	10,490,736
5/25/2023	Heather Ledbetter Prichard	COO	Sell	9,613	$3.83	$36,817.79	64,566
5/25/2023	Laura E. Niklason	CEO	Sell	2,625,000	$2.75	$7,218,750.00	15,365,736
12/16/2022	Brady W. Dougan	Director	Sell	239,538	$2.53	$606,031.14	17,990,736
12/16/2022	Dale A Sander	CFO	Buy	20,000	$2.60	$52,000.00	20,600
12/15/2022	Laura E. Niklason	CEO	Sell	93,426	$2.63	$245,710.38	18,230,274
12/14/2022	Brady W. Dougan	Director	Sell	276,304	$2.76	$762,599.04	18,323,700
12/13/2022	Laura E. Niklason	CEO	Sell	330,000	$2.84	$937,200.00	18,600,004
12/13/2022	William John Scheessele	Insider	Buy	5,000	$3.09	$15,450.00	15,525
9/15/2022	Brady W. Dougan	Director	Sell	1,522,500	$4.00	$6,090,000.00	18,930,004
9/15/2022	Laura E. Niklason	CEO	Buy	2,000	$4.14	$8,280.00	1,160,240
5/24/2022	William John Scheessele	Insider	Buy	10,525	$4.72	$49,678.00	10,525
5/23/2022	Laura E. Niklason	CEO	Buy	10,000	$4.83	$48,300.00	1,158,240
5/23/2022	Michael T. Constantino	Director	Buy	2,000	$4.83	$9,660.00	4,500
5/17/2022	Dale A Sander	CFO	Buy	2,000	$4.53	$9,060.00	2,000
12/16/2021	Brady W. Dougan	Director	Sell	75,000	$9.00	$675,000.00
12/15/2021	Laura E. Niklason	CEO	Sell	125,000	$8.88	$1,110,000.00
12/14/2021	Brady W. Dougan	Director	Sell	100,000	$9.44	$944,000.00
11/22/2021	Michael T. Constantino	Director	Buy	2,500	$10.79	$26,975.00

Trader Books $13M Profit on “Nvidia of Crypto”

From Crypto 101 Media | Ad

Click here to review my research and the strategy I've developed for the opportunity to trade this c

SEC Filings (Institutional Ownership Changes) for Humacyte (NASDAQ:HUMA)

44.71% of Humacyte stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Humacyte Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/15/2024	The Manufacturers Life Insurance Company	34,919	$0.17M	0.0%	+32.5%	0.029%
8/15/2024	Millennium Management LLC	1,599,307	$7.68M	0.0%	+504.3%	1.343%
8/15/2024	Deerfield Management Company L.P. Series C	322,851	$1.55M	0.0%	N/A	0.271%
8/15/2024	AQR Capital Management LLC	256,342	$1.23M	0.0%	+1,018.4%	0.215%
8/14/2024	Squarepoint Ops LLC	68,319	$0.33M	0.0%	-25.7%	0.057%
8/14/2024	Marshall Wace LLP	463,662	$2.23M	0.0%	+3,301.5%	0.389%
8/14/2024	Bank of Montreal Can	98,601	$0.50M	0.0%	N/A	0.083%
8/14/2024	ProShare Advisors LLC	15,554	$75K	0.0%	-14.8%	0.013%
8/14/2024	Profund Advisors LLC	20,271	$97K	0.0%	N/A	0.017%
8/12/2024	XTX Topco Ltd	22,877	$0.11M	0.0%	N/A	0.019%
8/9/2024	Renaissance Technologies LLC	600,300	$2.88M	0.0%	+693.0%	0.504%
8/5/2024	Private Advisor Group LLC	366,600	$1.76M	0.0%	+15.4%	0.308%
8/2/2024	Endowment Wealth Management Inc.	100,518	$0.48M	0.4%	+3.1%	0.084%
8/1/2024	Rhumbline Advisers	110,919	$0.53M	0.0%	+87.8%	0.093%
8/1/2024	United Asset Strategies Inc.	218,308	$1.05M	0.1%	-1.5%	0.183%
7/31/2024	nVerses Capital LLC	5,900	$28K	0.0%	N/A	0.005%
7/29/2024	Principal Financial Group Inc.	17,196	$83K	0.0%	N/A	0.014%
7/26/2024	Bank of New York Mellon Corp	254,013	$1.22M	0.0%	+62.7%	0.213%
7/24/2024	Bay Colony Advisory Group Inc d b a Bay Colony Advisors	14,550	$70K	0.0%	-35.2%	0.012%
7/17/2024	ARS Investment Partners LLC	116,419	$0.56M	0.1%	N/A	0.098%
5/20/2024	Virtu Financial LLC	63,403	$0.20M	0.0%	N/A	0.053%
5/14/2024	Anson Funds Management LP	50,000	$0.16M	0.0%	N/A	0.042%
5/10/2024	Vanguard Group Inc.	4,019,681	$12.50M	0.0%	+28.7%	3.376%
5/3/2024	GSA Capital Partners LLP	199,049	$0.62M	0.0%	-54.5%	0.167%
5/1/2024	Capstone Investment Advisors LLC	312,400	$0.97M	0.0%	N/A	0.262%
4/30/2024	Private Advisor Group LLC	317,624	$0.99M	0.0%	+232.7%	0.267%
4/30/2024	Hartline Investment Corp	22,450	$70K	0.0%	N/A	0.019%
4/29/2024	China Universal Asset Management Co. Ltd.	19,883	$62K	0.0%	+65.9%	0.017%
4/23/2024	Seven Grand Managers LLC	50,000	$0.16M	0.1%	N/A	0.042%
2/13/2024	Tower Research Capital LLC TRC	8,989	$26K	0.0%	+261.7%	0.009%
2/7/2024	Kovitz Investment Group Partners LLC	12,250	$35K	0.0%	N/A	0.012%
2/5/2024	Victory Capital Management Inc.	10,099	$29K	0.0%	N/A	0.010%
2/1/2024	Powell Investment Advisors LLC	21,000	$60K	0.0%	+75.0%	0.020%
1/30/2024	United Asset Strategies Inc.	221,308	$0.63M	0.1%	+53.9%	0.214%
1/30/2024	Imprint Wealth LLC	39,703	$0.12M	0.1%	-15.7%	0.038%
1/24/2024	China Universal Asset Management Co. Ltd.	11,986	$34K	0.0%	+350.4%	0.012%
1/12/2024	SG Americas Securities LLC	16,340	$46K	0.0%	+52.8%	0.016%
1/11/2024	Whittier Trust Co. of Nevada Inc.	10,000	$28K	0.0%	N/A	0.010%
11/15/2023	GSA Capital Partners LLP	355,918	$1.04M	0.1%	+139.5%	0.344%
11/15/2023	Rokos Capital Management LLP	200,000	$0.59M	0.0%	+122.5%	0.193%
11/14/2023	Clough Capital Partners L P	79,309	$0.23M	0.0%	N/A	0.077%
11/13/2023	Bay Colony Advisory Group Inc d b a Bay Colony Advisors	17,950	$53K	0.0%	N/A	0.017%
11/7/2023	United Asset Strategies Inc.	143,808	$0.42M	0.1%	-21.8%	0.139%
11/7/2023	Hamilton Lane Advisors LLC	21,893	$64K	0.0%	-58.5%	0.021%
11/7/2023	Barclays PLC	23,788	$70K	0.0%	-66.4%	0.023%
11/3/2023	Private Advisor Group LLC	94,980	$0.28M	0.0%	+126.1%	0.092%
10/30/2023	Private Management Group Inc.	15,500	$45K	0.0%	N/A	0.015%
10/23/2023	Commonwealth Equity Services LLC	12,580	$37K	0.0%	N/A	0.012%
10/16/2023	Powell Investment Advisors LLC	12,000	$35K	0.0%	N/A	0.012%
10/13/2023	SG Americas Securities LLC	10,695	$31K	0.0%	N/A	0.010%
9/12/2023	Davidson Kempner Capital Management LP	450,000	$1.28M	0.0%	N/A	0.435%
8/14/2023	Luminus Management LLC	400,000	$1.14M	0.3%	N/A	0.387%
8/14/2023	Shay Capital LLC	50,236	$0.14M	0.0%	+151.3%	0.049%
8/10/2023	Private Advisor Group LLC	42,000	$0.12M	0.0%	+42.4%	0.041%
7/31/2023	Curi Wealth Management LLC	35,440	$0.10M	0.0%	N/A	0.034%
7/31/2023	LPL Financial LLC	316,140	$0.90M	0.0%	+13.4%	0.306%
7/25/2023	United Asset Strategies Inc.	183,960	$0.53M	0.1%	+212.0%	0.178%
7/24/2023	Allspring Global Investments Holdings LLC	26,665	$76K	0.0%	+61.8%	0.026%
7/21/2023	Kovack Advisors Inc.	40,000	$0.11M	0.0%	+14.3%	0.039%
7/18/2023	Allspring Global Investments Holdings LLC	26,665	$76K	0.0%	+61.8%	0.026%
5/11/2023	Kovitz Investment Group Partners LLC	11,250	$35K	0.0%	N/A	0.011%
5/9/2023	Y Intercept Hong Kong Ltd	14,565	$45K	0.0%	N/A	0.014%
4/28/2023	SG Americas Securities LLC	29,921	$92K	0.0%	N/A	0.029%
4/25/2023	United Asset Strategies Inc.	58,960	$0.18M	0.0%	+114.7%	0.057%
4/21/2023	Kovack Advisors Inc.	35,000	$0.11M	0.0%	+40.0%	0.034%
4/14/2023	Raymond James & Associates	19,411	$60K	0.0%	N/A	0.019%
4/13/2023	Allspring Global Investments Holdings LLC	16,479	$51K	0.0%	N/A	0.016%
3/23/2023	MetLife Investment Management LLC	34,928	$74K	0.0%	N/A	0.034%
2/22/2023	Kovack Advisors Inc.	25,000	$53K	0.0%	N/A	0.024%
2/13/2023	The Manufacturers Life Insurance Company	15,218	$32K	0.0%	N/A	0.015%
2/7/2023	LPL Financial LLC	284,540	$0.60M	0.0%	-9.1%	0.276%
2/2/2023	ProShare Advisors LLC	16,093	$34K	0.0%	+51.7%	0.016%
2/1/2023	Gladstone Institutional Advisory LLC	12,098	$26K	0.0%	-86.2%	0.012%
1/26/2023	United Asset Strategies Inc.	27,460	$58K	0.0%	+83.6%	0.027%
1/18/2023	Private Advisor Group LLC	29,500	$62K	0.0%	+20.4%	0.029%
11/14/2022	Ergoteles LLC	31,276	$0.10M	0.0%	N/A	0.030%
11/14/2022	UBS Oconnor LLC	595,172	$1.94M	0.0%	-45.9%	0.578%
11/14/2022	York Capital Management Global Advisors LLC	1,399,424	$4.56M	1.0%	-38.9%	1.359%
11/8/2022	Hamilton Lane Advisors LLC	52,693	$0.17M	0.1%	N/A	0.051%
11/8/2022	New York State Common Retirement Fund	14,400	$47K	0.0%	-48.4%	0.014%
11/3/2022	Teacher Retirement System of Texas	18,343	$60K	0.0%	N/A	0.018%
10/31/2022	SG Americas Securities LLC	10,826	$35K	0.0%	N/A	0.011%
10/20/2022	Gladstone Institutional Advisory LLC	87,423	$0.29M	0.0%	-36.4%	0.085%
8/16/2022	Josh Arnold Investment Consultant LLC	22,000	$71K	0.1%	-39.2%	0.021%
8/9/2022	Swiss National Bank	133,500	$0.43M	0.0%	+9.6%	0.130%
8/3/2022	Valley Forge Investment Consultants Inc. ADV	11,000	$35K	0.0%	N/A	0.011%
8/2/2022	Powell Investment Advisors LLC	14,000	$45K	0.0%	N/A	0.014%
7/13/2022	Private Advisor Group LLC	24,500	$79K	0.0%	N/A	0.024%
5/17/2022	Prescott General Partners LLC	625,100	$4.41M	0.2%	+681.4%	0.607%
5/12/2022	Josh Arnold Investment Consultant LLC	36,171	$0.26M	0.2%	N/A	0.035%
5/4/2022	Wolverine Asset Management LLC	11,213	$79K	0.0%	-14.7%	0.011%
5/4/2022	Gladstone Institutional Advisory LLC	144,867	$1.02M	0.1%	-41.3%	0.141%
4/29/2022	United Asset Strategies Inc.	14,960	$0.11M	0.0%	+45.1%	0.015%
4/28/2022	Alphastar Capital Management LLC	10,767	$76K	0.0%	N/A	0.010%
4/26/2022	Sciencast Management LP	26,300	$0.18M	0.0%	N/A	0.026%
4/22/2022	Kovitz Investment Group Partners LLC	11,550	$82K	0.0%	N/A	0.011%
4/13/2022	Exos Asset Management LLC	18,609	$0.13M	0.1%	+15.3%	0.018%
4/4/2022	Dixon Hughes Goodman Wealth Advisors LLC	6,750	$48K	0.0%	N/A	0.007%
3/14/2022	Exos Asset Management LLC	16,139	$0.12M	0.1%	-14.8%	0.016%
2/15/2022	Diameter Capital Partners LP	300,338	$2.18M	0.1%	-68.5%	0.292%

Data available starting January 2016

Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.

Today's Range

Now: $5.62

$5.45

$5.93

50 Day Range

MA: $6.93

$5.25

$9.46

52 Week Range

Now: $5.62

$1.96

$9.97

Volume

2,076,164 shs

Average Volume

2,199,793 shs

Market Capitalization

$669.25 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Who are the company insiders with the largest holdings of Humacyte?: Humacyte's top insider investors include:
Brady W Dougan (Director)
Laura E Niklason (CEO)
Gordon M Binder (Director)
Heather Ledbetter Prichard (COO)
Kathleen Sebelius (Director)
Dale A Sander (CFO)
William John Scheessele (Insider)
Learn More about top insider investors at Humacyte.
Who are the major institutional investors of Humacyte?: Humacyte's top institutional shareholders include:
Millennium Management LLC — 1.34%
Renaissance Technologies LLC — 0.50%
Marshall Wace LLP — 0.39%
Private Advisor Group LLC — 0.31%
Deerfield Management Company L.P. Series C — 0.27%
AQR Capital Management LLC — 0.22%
Learn More about top institutional investors of Humacyte stock.
Which major investors are selling Humacyte stock?: In the last quarter, HUMA stock was sold by these institutional investors:
Squarepoint Ops LLC
Bay Colony Advisory Group Inc d b a Bay Colony Advisors
United Asset Strategies Inc.
ProShare Advisors LLC
Within the last year, company insiders that have sold Humacyte company stock include:
Brady W Dougan (Director)
Laura E Niklason (CEO)
Gordon M Binder (Director)
Heather Ledbetter Prichard (COO)
Kathleen Sebelius (Director)
Learn More investors selling Humacyte stock.
Which major investors are buying Humacyte stock?: In the previous quarter, HUMA stock was purchased by institutional investors including:
Millennium Management LLC
Renaissance Technologies LLC
Marshall Wace LLP
Deerfield Management Company L.P. Series C
AQR Capital Management LLC
ARS Investment Partners LLC
Bank of Montreal Can
Bank of New York Mellon Corp
In the last year, these company insiders have bought Humacyte stock:
Brady W Dougan (Director)
Laura E Niklason (CEO)
Gordon M Binder (Director)
Heather Ledbetter Prichard (COO)
Kathleen Sebelius (Director)
Learn More investors buying Humacyte stock.